VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896

System,test,antibodies,b2 - Glycoprotein I (b2 - Gpi)

PHARMACIA DEUTSCHLAND GMBH

The following data is part of a premarket notification filed by Pharmacia Deutschland Gmbh with the FDA for Varelisa B2 Glycoprotein I Igm Antibodies, Models 18848 And 18896.

Pre-market Notification Details

Device IDK040451
510k NumberK040451
Device Name:VARELISA B2 GLYCOPROTEIN I IGM ANTIBODIES, MODELS 18848 AND 18896
ClassificationSystem,test,antibodies,b2 - Glycoprotein I (b2 - Gpi)
Applicant PHARMACIA DEUTSCHLAND GMBH DIAGNOSTICS DIVISION MUNZINGER STRASSE 7 Freiburg,  DE D-79111
ContactMichael Linss
CorrespondentMichael Linss
PHARMACIA DEUTSCHLAND GMBH DIAGNOSTICS DIVISION MUNZINGER STRASSE 7 Freiburg,  DE D-79111
Product CodeMSV  
CFR Regulation Number866.5660 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2004-02-20
Decision Date2004-05-11
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.